1-13 of 13
Graham Collins
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bexobrutideg (NX-5948), a novel Bruton's tyrosine kinase (BTK) degrader, shows high clinical activity and tolerable safety in patients with Waldenström macroglobulinemia: Updated results from an ongoing Phase 1a/b study

Free
Nirav Shah, Scott Huntington, David Lewis, Talha Munir, Graham Collins, Alvaro Alencar, Kim Linton, Zulfa Omer, Dima El-Sharkawi, Mary Gleeson, Pamela McKay, Jeanette Doorduijn, Jeffery Smith, Daniel Morillo, Pau Abrisqueta, Sarah Injac, Astrid Pulles
Journal: Blood
Blood (2025) 146 (Supplement 1): 5359.
https://doi.org/10.1182/blood-2025-5359
Published: 2025
Journal Articles

Randomised Phase II study of acalabrutinib in combination with R-CHOP treatment for diffuse large B-cell lymphoma confirms safety and unimpaired treatment delivery

Free
Louise Stanton, Geoffrey Saunders, Sharon Barrans, Joshua Caddy, Katy McLaughlin, Pamela McKay, Antonina Zhelyazkova, Graham Collins, Christopher Fox, Jamie Wilson, Abigail Morgan-Fox, Jackie Raftery, Julie Richardson-Abraham, Oliver Seymour, Katie Mansell, Tracey Mell, Moniek Van Hoppe, Alessandra Serra, Gareth Griffiths, Victoria Warbey, Vivek Radhakrishnan, Pavel Mozgunov, Sally Barrington, Cathy Burton, Peter Johnson, Andrew Davies
Journal: Blood
Blood (2025) 146 (Supplement 1): 5459.
https://doi.org/10.1182/blood-2025-5459
Published: 2025
Journal Articles

Bexobrutideg (NX-5948), a novel Bruton's tyrosine kinase (BTK) degrader, demonstrates rapid and durable clinical responses in Relapsed/Refractory chronic lymphocytic leukemia (CLL): New and updated findings from an ongoing Phase 1a/b trial

Free
Zulfa Omer, Alexey Danilov, Francesco Forconi, Talha Munir, Mary Gleeson, Nirav Shah, Graham Collins, Alvaro Alencar, Jane Robertson, Jonathon Cohen, Karan Dixit, Danielle Brander, John Byrd, Allison Winter, Jeffery Smith, Dima El-Sharkawi, Michal Kwiatek, Iwona Hus, Prioty Islam, Sebastian Grosicki, Michael Tees, Thorsten Zenz, Joanna Romejko-Jarosinska, Sarah Injac, Wojciech Jurczak
Journal: Blood
Blood (2025) 146 (Supplement 1): 86.
https://doi.org/10.1182/blood-2025-86
Published: 2025
Journal Articles

Relapsed/Refractory Hodgkin lymphoma after first-line escalated beacopdac: Adverse outcomes are overcome by use of second-line targeted therapy - an international real-world analysis

Free
Lisa Jeffers, Anna Santarsieri, Wendy Osborne, Florian Chevillon, Agathe Vely, Vandita Bhartia, Graham Collins, Aisling Barrett, Maria Marzolini, Lindsay George, Kaljit Bhuller, Cathy Burton, Sharon-Rose Ogome, Nimish Shah, Sunil Iyengar, Laura McDonald, Vivek Radhakrishnan, Harshani Jayakody, Emily Chernucha, Dominic Culligan, Abhinav Mathur, Pamela McKay, Fatima Jamil, Elizabeth Phillips
Journal: Blood
Blood (2025) 146 (Supplement 1): 3623.
https://doi.org/10.1182/blood-2025-3623
Published: 2025
Journal Articles

18 f-FDG PET-CT Assessment of Responses to Salvage Therapy and Autologous Stem Cell Transplant (ASCT) in Relapsed/Refractory Classical Hodgkin Lymphoma (cHL)

Free
Maciej Tatarczuch, BMBS, FRACP, FRCPA, Catherine Hildyard, MRCP, BA, Manil Subesinghe, MBBS, MRCP, FRCR., Toby A. Eyre, MBBChir, MRCP, Graham Collins, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5181.
https://doi.org/10.1182/blood.V130.Suppl_1.5181.5181
Published: 2017
Journal Articles

Nivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 Checkmate 205 Study

Free
Jonathon B Cohen, MDMS, Andreas Engert, MD, Stephen M Ansell, MD PhD, Anas Younes, MD, Marek Trneny, MD, Kerry J Savage, BSc, MD MSc, Radhakrishnan Ramchandren, MD, Graham Collins, MD PhD, Michelle A. Fanale, MD, Philippe Armand, MD PhD, Pier Luigi Zinzani, MD PhD, Jan Paul De Boer, MD PhD, Margaret A. Shipp, MD, Armando Santoro, MD, John M Timmerman, MD, Mariana Sacchi, Oumar Sy, PhD, John Kuruvilla, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 650.
https://doi.org/10.1182/blood.V130.Suppl_1.650.650
Published: 2017
Journal Articles

A Phase II Study to Determine the Safety and Efficacy of the Dual m-TORC Inhibitor AZD2014 and to Investigate Additional Toxicities in Combination with Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Free
Toby A. Eyre, MBBChir, MRCP, Catherine Hildyard, MRCP, BA, Anesh Panchal, BSc, MSc, Aimee E Houlton, BSc, MSc, Louise Hopkins, BSc, MRes, Angela Hamblin, MD PhD, Kim Linton, MBChB PhD, Andrew Pettitt, FRCPath, PhD, Simon Rule, MD, Kate Cwynarski, PhD MD, Sally Barrington, MBBS, MSc, FRCP, FRCR, MD, David Wrench, MA, MBBChir, FRCPath, PhD, Andrew Davies, PhD, Graham Collins, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5210.
https://doi.org/10.1182/blood.V130.Suppl_1.5210.5210
Published: 2017
Journal Articles

HM-PRO: A Novel Patient-Reported Outcome Measure in Hematological Malignancy for Use in Clinical Practice

Free
Pushpendra Goswami, PhD MSc, BPharm, Sam Salek, PhDRPh FFPM MCMS MRPSGB FESCP, Tatyana Ionova, PhD, Esther Natalie Oliva, MD, Adele K Fielding, MBBS,PhDFRCP,FRCPath, Marina Karakantza, MD, Saad Al-Ismail, MD, Graham Collins, MD PhD, Stewart McConnell, Catherine Langton, Daniel Jennings, Roger Else, William J. Kell, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2176.
https://doi.org/10.1182/blood.V130.Suppl_1.2176.2176
Published: 2017
Journal Articles

Ibrutinib Therapy in Patients with Relapsed/Refractory Marginal Zone Lymphoma: Analysis By Prior Rituximab Treatment and Baseline Mutations

Free
Robert Chen, MD, Sven de Vos, MD PhD, Catherine Thieblemont, MD PhD, Peter Martin, FRCPC, MD MS, Christopher Flowers, MD, Franck Morschhauser, MD PhD, Graham Collins, MD PhD, Shuo Ma, MD, Morton Coleman, MD, Shachar Peles, MD, Stephen D. Smith, MD, Jacqueline C. Barrientos, MD, Alina Smith, Brian Munneke, PhD, Shiquan Wu, PhD, Leo Cheung, PhD, Kevin Kwei, PhD, Selda Samakoglu, MD PhD, Israel Arango-Hisijara, MD, Isaiah Dimery, MD, Ariela Noy, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3026.
https://doi.org/10.1182/blood.V130.Suppl_1.3026.3026
Published: 2017
Journal Articles

Expression of Major Histocompatibility Complex (MHC) Class II, but Not MHC Class I, Predicts Outcome in Patients with Classical Hodgkin Lymphoma (cHL) Treated with Nivolumab (Programmed Death-1 [PD-1] Blockade)

Free
Margaretha G.M. Roemer, MSc, Robert A. Redd, MS, Fathima Zumla Cader, MD PhD MRCP, Christine J. Pak, Sara Abdelrahman, Jing Ouyang, Stephanie Sasse, MD, Anas Younes, MD, Michelle A. Fanale, MD, Armando Santoro, MD, Pier Luigi Zinzani, MD, John M Timmerman, MD, Graham Collins, MD PhD, Rod Ramchandren, MD, Jonathon B Cohen, MDMS, Jan Paul De Boer, MD PhD, John Kuruvilla, MD, Kerry J Savage, BSc, MD MSc, Marek Trneny, MD, Stephen M Ansell, MD PhD, Mariana Sacchi, Benedetto Farsaci, MD, Anne Sumbul, Philippe Armand, MD PhD, Donna S. Neuberg, ScD, Geraldine S. Pinkus, Azra H. Ligon, Scott J. Rodig, MDPhD, Margaret A. Shipp, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1450.
https://doi.org/10.1182/blood.V130.Suppl_1.1450.1450
Published: 2017
Journal Articles

Interim Results from a Phase 1 Study of ADCT-301 (Camidanlumab Tesirine) Show Promising Activity of a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate in Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma

Free
Steven M. Horwitz, MD, Mehdi Hamadani, MD, Michelle A. Fanale, MD, Jay Feingold, MD PhD, Alexander I Spira, MD, Paul A Fields, MD PhD, Tobias Menne, MD PhD, Anand Karnad, MD, Alison J. Moskowitz, MD, Catherine Hildyard, MRCP, BA, Shui He, PhD, Joseph Boni, PhD, Graham Collins, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1510.
https://doi.org/10.1182/blood.V130.Suppl_1.1510.1510
Published: 2017
Journal Articles

Cytotoxic T-Cell Response to the Cancer Testis Antigen PASD1 In Multiple Myeloma: PASD1 Peptides for a Generic Vaccine to Treat PASD1-Positive Haematological Malignancies

Free
Andrew J Campbell, MD, PhD, Kamel Ait-Tahar, PhD, Suketu D. Patel, MSc, Martin Barnardo, FRCPath, Amanda P Liggins, BSc, PhD, Maite Caibes, BSc, Alison Banham, DPhil, Graham Collins, MD, PhD, Chris S.R Hatton, MD, Karen Pulford, PhD, FRCPath
Journal: Blood
Blood (2010) 116 (21): 4294.
https://doi.org/10.1182/blood.V116.21.4294.4294
Published: 2010
Journal Articles

Identification of Circulating Autoantibodies in Patients with Lymphoma Using Antigen Arrays.

Free
Karen Pulford, PhD, Hong Chen, MD, Kamel Ait-Tahar, PhD, Amanda P. Liggins, PhD, Christopher D.O. Cooper, MSc, Graham Collins, MRCP, Chris S.R. Hatton, MRCPath, Edith Gould, BSc, David Toomey, PhD, Alison H. Banham, DPhil, Derek Murphy, PhD
Journal: Blood
Blood (2006) 108 (11): 2397.
https://doi.org/10.1182/blood.V108.11.2397.2397
Published: 2006